thiophenes has been researched along with pepstatin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eng, K; Galloway, AC; Marcus, SG; Mignatti, P; Monea, S; Patel, S; Schwartz, JD; Shamamian, P | 1 |
| Galloway, AC; Marcus, SG; Mignatti, P; Monea, S; Schwartz, JD; Shamamian, P; Whiting, D | 1 |
2 other study(ies) available for thiophenes and pepstatin
| Article | Year |
|---|---|
Soluble factor(s) released from neutrophils activates endothelial cell matrix metalloproteinase-2.
Topics: Aprotinin; Cells, Cultured; Culture Media, Conditioned; Cysteine Proteinase Inhibitors; Endothelium, Vascular; Enzyme Activation; Gelatinases; Humans; Leucine; Matrix Metalloproteinase 2; Metalloendopeptidases; Neutrophil Activation; Neutrophils; Pepstatins; Phenanthrolines; Phenylalanine; Protease Inhibitors; Proteins; Serine Proteinase Inhibitors; Serpins; Solubility; Thiophenes; Time Factors; Umbilical Veins | 1998 |
Activation of tumor cell matrix metalloproteinase-2 by neutrophil proteinases requires expression of membrane-type 1 matrix metalloproteinase.
Topics: alpha 1-Antitrypsin; Aprotinin; Collagenases; Cysteine Proteinase Inhibitors; Endopeptidases; Enzyme Activation; Enzyme Precursors; Fibrosarcoma; Gelatinases; Humans; Leucine; Matrix Metalloproteinase 1; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Metalloendopeptidases; Neoplasm Invasiveness; Neutrophils; Pepstatins; Phenylalanine; Protease Inhibitors; Serine Proteinase Inhibitors; Thiophenes; Transfection; Tumor Cells, Cultured | 1998 |